What is Tango Therapeutics's total?

Tango Therapeutics (TNGX) reported total of $222.13M in Q1 2026.

How has Tango Therapeutics's total changed year-over-year?

Tango Therapeutics's total increased by 40.5% year-over-year, from $158.1M to $222.13M.

What is the long-term trend for Tango Therapeutics's total?

Over 5 years (2020 to 2025), Tango Therapeutics's total has grown at a 7.3% compound annual growth rate (CAGR), from $161.92M to $230.64M.

Tango Therapeutics TNGX Total

Total at other companies

AmgenAMGN

——

ExelixisEXEL

——

Guardant HealthGH

——

ModernaMRNA

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's total?: Tango Therapeutics (TNGX) reported total of $222.13M in Q1 2026.
How has Tango Therapeutics's total changed year-over-year?: Tango Therapeutics's total increased by 40.5% year-over-year, from $158.1M to $222.13M.
What is the long-term trend for Tango Therapeutics's total?: Over 5 years (2020 to 2025), Tango Therapeutics's total has grown at a 7.3% compound annual growth rate (CAGR), from $161.92M to $230.64M.